Weber Barbara 4
4 · Revolution Medicines, Inc. · Filed Oct 10, 2024
Insider Transaction Report
Form 4
Weber Barbara
Director
Transactions
- Sale
Common Stock
2024-10-08$48.02/sh−5,200$249,716→ 13,065 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 29, 2024.
- [F2]The transaction was executed in multiple trades in prices ranging from $48.00 to $48.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 4,248 restricted stock units.